Clataaz 4000mg/500mg Injection
Marketer
Clabert Lifesciences Pvt Ltd
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Clataaz 4000mg/500mg Injection
The dual-antibiotic injection, Clataaz 4000mg/500mg, combats diverse bacterial infections by eliminating microorganisms. Administered solely by medical professionals, its dosage and frequency are determined by a physician based on individual patient needs and illness severity. Strict adherence to prescribed usage is crucial. Commonly reported side effects encompass nausea, vomiting, diarrhea, and skin rashes; injection site reactions such as pain, swelling, or redness are also possible. Persistent or worsening side effects warrant immediate medical consultation. Prior to treatment, disclose any antibiotic allergies, kidney, or liver issues; adjustments to dosage or alternative medications may be necessary. Under professional guidance, Clataaz 4000mg/500mg is generally considered safe during pregnancy and lactation.
Uses of Clataaz 4000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Clataaz 4000mg/500mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Clataaz 4000mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Clataaz 4000mg/500mg Injection:
This medication will be administered by your physician or their nursing staff; self-medication is strictly prohibited.
How Clataaz 4000mg/500mg Injection works:
Clataaz 4000mg/500mg injection unites piperacillin, a potent antibiotic, with tazobactam, a beta-lactamase inhibitor. Piperacillin's mechanism involves disrupting bacterial cell wall synthesis, a vital process for bacterial viability. Tazobactam counters bacterial resistance, thus bolstering piperacillin's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Clataaz 4000mg/500mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Clataaz, 4000mg/500mg, is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no harmful consequences for the fetus; nonetheless, clinical data from human subjects remain scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Clataaz (4000mg/500mg) is considered safe for breastfeeding mothers. Research in humans indicates negligible transfer of the drug into breast milk, posing no known risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Clataaz 4000mg/500mg Injection on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneyCAUTION
The administration of Clataaz 4000mg/500mg Injection requires careful consideration in individuals with impaired renal function. Dosage modifications for Clataaz 4000mg/500mg Injection may be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Clataaz 4000mg/500mg Injection in patients with hepatic impairment is likely safe. Existing evidence indicates dose modification may be unnecessary for this patient population, however, physician consultation is recommended.
What if you forget to take Clataaz 4000mg/500mg Injection :
Omitting a scheduled dose of Clataaz 4000mg/500mg Injection necessitates contacting your physician.
Facts to Know About Clataaz 4000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently